Sofie Haedersdal
Copenhagen, 2100, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Glycaemic variation and atrial fibrillation burden and progression in individuals without diabetes undergoing continuous rhythm monitoring.
Journal: International journal of cardiology
Published: May 18, 2026
Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.
Journal: Current diabetes reports
Published: January 05, 2026
The health risks and treatment options for women with overweight or obesity seeking pregnancy
Journal: Ugeskrift for laeger
Published: September 05, 2025
Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trial.
Journal: Diabetologia
Published: March 16, 2025
Effects of Atrial Fibrillation Screening According to Thyroid Function: Post Hoc Analysis of the Randomized LOOP Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 19, 2024
Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3).
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: April 12, 2024
SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts.
Journal: The Journal of clinical investigation
Published: October 17, 2023
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases.
Journal: Nature reviews. Endocrinology
Published: February 17, 2023
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes.
Journal: European journal of endocrinology
Published: April 03, 2022
Last Updated: 09/26/2026